Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.56 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.56 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.52 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29726014 | 1.00 | CASP1 (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL27632859 | 1.00 | CASP1 (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| Hydrochloric Acid SCHEMBL7402731 | 0.98 | CASP1 (0.57) | CASP1CASP7HSD17B10PARP10PARP11 | |
| Acetic Acid SCHEMBL27953675 | 0.91 | CASP1 (0.50) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL1027718 | 0.88 | MAOA (0.61) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL7916500 | 0.88 | MAOA (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| Dimethylformamide SCHEMBL7844770 | 0.88 | CASP1 (0.47) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL7435588 | 0.84 | METAP1 (0.60) | PARP10PARP11SRD5A1METAP1MAOA | |
| SCHEMBL1747435 | 0.84 | HSD17B1 (0.69) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL19422232 | 0.84 | PARP10 (0.55) | PARP10PARP11SRD5A1METAP1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861113-B | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-113861113-A | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2021-12-31 | — | — | CN | claimed |
| US-10043978-B2 | Organic semiconductor formulations | FLEXTERRA, INC. (US) | 2018-08-07 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| EP-4098670-B1 | BIMODAL POLY(ETHYLENE-CO-1-ALKENE) COPOLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260001977-A1 | BIMODAL POLY(ETHYLENE-CO-1-ALKENE) COPOLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12441748-B2 | Metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-10-14 | — | — | US | disclosed |
| WO-2025101264-A1 | MULTIMODAL POLYETHYLENE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-05-15 | — | — | WO | disclosed |
| CN-113748140-B | Metal-ligand complexes | 陶氏环球技术有限责任公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250066357-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2025034361-A1 | MULTIMODAL POLYETHYLENE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-02-13 | — | — | WO | disclosed |
| US-20250009924-A1 | Indane Derivatives for Malodor Counteraction | FIRMENICH SA (CH) | 2025-01-09 | — | — | US | disclosed |
| US-5877218-A | PARKINSON'S DISEASE; ANTIEPILEPSY AGENTS; ANTICONVULSANTS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1999-03-02 | — | — | US | disclosed |
| US-5877221-A | TREATING DEMENTIA | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1999-03-02 | — | — | US | disclosed |
| EP-0662971-B1 | 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | RHONE POULENC RORER SA (FR) | 1998-05-13 | — | — | EP | disclosed |
| US-5677306-A | ANTAGONIZING ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTOR, USEFUL FOR TREATING ALL ISCHEMIAS | RHONE-POULENC RORER S.A. (FR) | 1997-10-14 | — | — | US | disclosed |
| US-5639913-A | TREATMENT OF PARKINSON'S DISEASE, DEMENTIA, EPILEPSY | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1997-06-17 | — | — | US | disclosed |
| EP-0662971-A1 | DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | Aventis Pharma S.A. (FR) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994007893-A1 | DERIVATIVES OF 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1994-04-14 | — | — | WO | disclosed |
| EP-0240859-B1 | LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1993-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009924-A1 | Indane Derivatives for Malodor Counteraction | MAL2, MTNR1A, LPO | CASP1 3855/4885CASP7 4420/4885HSD17B10 712/4885 |
| US-20250066357-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS | PPM1A, PPM1F, PPP5C | CASP1 3217/4885CASP7 2841/4885HSD17B10 2047/4885 |
| US-12441748-B2 | Metal-ligand complexes | ARL1, CRKL, SAAL1 | CASP1 3590/4885CASP7 3138/4885HSD17B10 4162/4885 |
| US-20260001977-A1 | BIMODAL POLY(ETHYLENE-CO-1-ALKENE) COPOLYMER | EIF2AK1, ASH2L, SMARCC1 | CASP1 1809/4885CASP7 2689/4885HSD17B10 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.